Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 9Uterine Cervical Dysplasia 3Melanoma 3Breast Neoplasms 3Squamous Intraepithelial Lesions 2Papillomavirus Infections 2HIV Infections 2Condylomata Acuminata 2Vulvar Neoplasms 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Squamous Cell Carcinoma of Head and Neck 1Sexually Transmitted Diseases 1Pigmentation Disorders 1Neoplasms 1Keratosis 1Hemangioma, Capillary 1Glioblastoma 1Breast Neoplasms, Male 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

VP-102 1Therapies, Investigational 1Imiquimod 1Community Health Workers 1Cantharidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sexually Transmitted Diseases × Imiquimod × Clear all
NCT02482428 2021-01-05

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Novartis

Phase 2 Completed
88 enrolled 10 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡